Target intelligence / Profile preview

Glyoxylate cycle (GS)

Target
GS
Molecular classification
Metabolic pathway, Enzyme system
01

Overview

The glyoxylate cycle, also known as the glyoxylate shunt, is a metabolic pathway found in plants, bacteria, and fungi, but it is notably absent in mammals. This pathway functions as an anabolic variant of the tricarboxylic acid (TCA) cycle, bypassing the two carbon-dioxide-generating decarboxylation steps to convert two-carbon acetyl-CoA units into four-carbon succinate and malate. In pathogenic microorganisms, such as Mycobacterium tuberculosis and Candida albicans, the glyoxylate cycle is essential for carbon assimilation and gluconeogenesis when simple sugars are unavailable, particularly during survival inside host macrophages. Because the key enzymes of the cycle, isocitrate lyase and malate synthase, have no human counterparts, they represent high-value therapeutic targets for the development of selective antimicrobial and antifungal agents. Inhibiting this cycle effectively disrupts the ability of latent pathogens to maintain energy levels and synthesize essential biomass from host-derived lipids. Current research focuses on developing selective inhibitors like phenyl-diketo acids and itaconate derivatives to combat persistent and drug-resistant infections. Despite its potential, therapeutic development is challenged by the need for high enzyme specificity to avoid off-target effects on the host's central metabolism.

Other names
Glyoxylate shuntGlyoxylate bypassGlyoxylate pathway
02

Mechanism of action

Inhibition of key enzymes isocitrate lyase and malate synthase to disrupt the bypass of the tricarboxylic acid (TCA) cycle, thereby preventing the conversion of 2-carbon compounds into 4-carbon dicarboxylic acids required for gluconeogenesis and energy production in pathogens.

03

Biological functions

Carbon assimilationAnabolismGluconeogenesisLipid metabolismPathogen persistence
04

Disease associations

InfectionTuberculosisCandidiasisFungal infectionParasitic infection
05

Safety considerations

Potential off-target inhibition of host mitochondrial enzymes like succinate dehydrogenase (SDH)Neurotoxicity in mammals caused by non-specific mitochondrial disruption (e.g., by 3-nitropropionate)Therapeutic challenge of drug delivery to dormant pathogens residing in low-oxygen, nutrient-poor granulomas
06

Interacting drugs

Itaconate

7 more in the full profile.

07

Biomarkers

Isocitrate lyase (ICL) activityBacterial ICL1 gene expressionBacterial glyoxylate levelsPathogen survival in acetate/fatty acid-rich environments

Beyond the preview

Go deeper on Glyoxylate cycle (GS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glyoxylate cycle (GS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call